Does TIGECYCLINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with TIGECYCLINE (Tigecycline). This represents 0.2% of all adverse event reports for TIGECYCLINE.
6
Reports of Malignant neoplasm progression with TIGECYCLINE
0.2%
of all TIGECYCLINE reports
5
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TIGECYCLINE?
Of the 6 reports, 5 (83.3%) resulted in death, 4 (66.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIGECYCLINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TIGECYCLINE Cause?
Drug ineffective (486)
Off label use (473)
Nausea (257)
Vomiting (174)
Coagulopathy (173)
Thrombocytopenia (150)
Drug resistance (148)
Sepsis (123)
Pathogen resistance (122)
Death (121)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TIGECYCLINE Alternatives Have Lower Malignant neoplasm progression Risk?
TIGECYCLINE vs TIKOSYN
TIGECYCLINE vs TILDRAKIZUMAB
TIGECYCLINE vs TILDRAKIZUMAB-ASMN
TIGECYCLINE vs TILIDINE
TIGECYCLINE vs TIMOLOL